In another cross-sectional pilot study , we confirmed that the levels of CSF - synuclein oligomers were higher in patients with PD ( n = 25 ) compared to patients with PSP ( n = 18 ; p < 0.05 ) or AD ( n = 35 ; p < 0.001 ) or control subjects ( n = 43 ; p < 0.05 ) .
